Global Molecular Quality Controls Market – Industry Trends and Forecast to 2029

Market Analysis and Insights

The emergence of transmissible and genetic diseases is increasing the need for critical and accurate diagnostic information in order to determine these diseases. Molecular quality control is the testing and reporting of any irregularity in diagnostic products that may affect laboratory product decisions.

• Early detection of potential anomalies is crucial for laboratories as they assist in implementing a timely response and avoid negative impacts on patient data. Data Bridge Market Research analyses that the molecular quality controls market is estimated to grow at a 10.35% during the forecast period of 2022 to 2029.

Molecular Quality Controls Market Dynamics

Drivers

• Increase in the Prevalence of Genetic Diseases

The increase in the prevalence of genetic disorders such as Downs’s syndrome acts as one of the major factors driving the growth of molecular quality controls market. The testing process is widely used in the detection of genetic diseases as these assist in the interpretation of results.

• Adoption of Third-Party Quality Controls

The rise in the adoption of third-party quality controls due to the need for robust diagnostic methods and effective treatment accelerates market growth.

• Surge in Number of Accredited Clinical Laboratories

The surge in the number of accredited clinical laboratories due to the rising prevalence of cancers, HIV, and other diseases that require effective diagnostic methods helps in the expansion of the market.

• Financial support to the researchers for developing novel intervention

Various public and private organizations are increasing their investments in developing novel interventions and treatments that enhance the market.

Additionally, increase in demand for effective therapies, surge in healthcare expenditure, prevalence of HIV infection, population growth, changes in lifestyle and rise in demand for external quality assessment support positively affect the molecular quality controls market.

Opportunities

Furthermore, rise in demand for multi-analyte controls extends profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, high investments by government and private organization will escalate the growth of molecular quality controls market in the above mentioned forecast period.

Restraints/Challenges

On the other hand, high cost associated with the quality control and budget constraints in hospitals and laboratories, and unfavorable reimbursement scenario for molecular tests are expected to obstruct the market growth. Lack of mandatory regulations for clinical laboratory accreditation and complex regulatory frameworks are projected to challenge the molecular quality controls market in the forecast period of 2022-2029.

This molecular quality controls market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on molecular quality controls market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Healthcare Infrastructure growth Installed base and New Technology Penetration

The molecular quality controls market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for molecular quality controls market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the molecular quality controls market. The data is available for historic period 2010-2020.

COVID-19 Impact on Molecular Quality Controls Market

The COVID-19 has negatively affected the market. Lockdowns and isolation during pandemics complicate the disease management and medication adherence. The lack of access to healthcare facilities for routine treatment and medication administration will further affect the market. Social isolation increases stress, despair, and social support, all of which may cause a reduction in medication adherence during the pandemic.

Global Molecular Quality Controls Market Scope

The molecular quality controls market is segmented on the basis of product, analyte type, application and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product

• Independent Controls
• Instrument-Specific Controls

Based on product, molecular quality controls market is segmented into independent controls, instrument-specific controls. Instrument-specific controls have been further segmented into PCR, DNA sequencing & NGS, other technologies.

Analyte Type

• Single-Analyte Controls
• Multi-Analyte Controls

Based on analyte type, molecular quality controls market is segmented into single-analyte controls and multi-analyte controls.

Application

• Infectious Diseases
• Oncology
• Genetic Testing
• Other Applications

Based on application, molecular quality controls market is segmented into infectious diseases, oncology, genetic testing and other applications.

End User

• Clinical Laboratories
• Hospitals
• IVD Manufacturers And Contract Research Organizations
• Academic and Research Institutes
• Other End Users

Molecular quality controls market has also been segmented based on the end user into clinical laboratories, hospitals, IVD manufacturers and contract research organizations, academic and research institutes, and other end users.

Pipeline Analysis

Molecular quality controls are essential in the detection of various diseases for the interpretation of results. Independent controls and instrument-specific controls are widely being used in laboratories throughout the world. SeraCare Life Sciences, Inc., Thermo Fisher Scientific Inc., and Bio-Rad Laboratories, Inc., are some of the manufacturers involved with the development of quality controls.

Molecular Quality Controls Market Regional Analysis/Insights

The molecular quality controls market is analysed and market size insights and trends are provided by country, product, analyte type, application and end user as referenced above.

The countries covered in the molecular quality controls market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the molecular quality controls market due to the presence of well-developed healthcare infrastructure and increase in number of laboratories within the region.

Asia-Pacific is expected to witness high growth during the forecast period of 2022 to 2029 because of the increase in the prevalence of infectious and genetic disorders in the region.

The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

Competitive Landscape and Molecular Quality Controls Market Share Analysis

The molecular quality controls market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to molecular quality controls market.

Some of the major players operating in the molecular quality controls market are SeraCare Life Sciences, Inc., Thermo Fisher Scientific Inc., Bio-Rad Laboratories, Inc., Microbiologics, Inc., ZeptoMetrix Corporation, F. Hoffmann-La Roche Ltd, Abbott Laboratories, Quidel Corporation, Qnostics, Maine Molecular Quality Controls, INC., Danaher., Helena Biosciences Europe, SERO AS, Technopath Clinical Diagnostics, and Randox Laboratories Ltd., among others.

SKU-52153